| Mand R Medical Supply Corp | |
| 162 Avenue U, Brooklyn, New York 11223 | |
| (718) 714-0822 |
| Name | Mand R Medical Supply Corp |
|---|---|
| Organization Name | M & R Medical Supply Corp. |
| Location | 162 Avenue U, Brooklyn, New York 11223 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (718) 714-0822 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that it has been awarded a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense (DOD), focused on identifying and advancing novel technologies to support defense of our nation's soldiers and civilian population.
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.
Garvan Institute scientists have discovered how a hormone, known as neuropeptide Y (NPY), can prevent our immune system functioning properly, paving the way for two new major opportunities for therapeutic intervention.
Twenty states and the District of Columbia have agreed to expand their Medicaid programs, to cover everyone under 133 percent of the federal poverty line. That leaves 30 states that haven't, although Avalere categorizes four states as leaning in that direction (Tennessee, Kentucky, Florida and New York). Some of these states have especially large uninsured populations.
A shortage of oncologists and rising costs of chemotherapy and radiation therapies and imaging tests, are making delivering quality cancer care increasingly difficult, according to a new review by researchers at RTI International and Eli Lilly and Company.
› Verified 5 days ago
| NPI Number | 1265447650 |
| Organization Name | M & R MEDICAL SUPPLY CORP. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 162 Avenue U, Brooklyn, NY 11223 |
| Phone Number | 718-714-0822 |
News Archive
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that it has been awarded a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense (DOD), focused on identifying and advancing novel technologies to support defense of our nation's soldiers and civilian population.
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.
Garvan Institute scientists have discovered how a hormone, known as neuropeptide Y (NPY), can prevent our immune system functioning properly, paving the way for two new major opportunities for therapeutic intervention.
Twenty states and the District of Columbia have agreed to expand their Medicaid programs, to cover everyone under 133 percent of the federal poverty line. That leaves 30 states that haven't, although Avalere categorizes four states as leaning in that direction (Tennessee, Kentucky, Florida and New York). Some of these states have especially large uninsured populations.
A shortage of oncologists and rising costs of chemotherapy and radiation therapies and imaging tests, are making delivering quality cancer care increasingly difficult, according to a new review by researchers at RTI International and Eli Lilly and Company.
› Verified 5 days ago
News Archive
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that it has been awarded a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense (DOD), focused on identifying and advancing novel technologies to support defense of our nation's soldiers and civilian population.
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.
Garvan Institute scientists have discovered how a hormone, known as neuropeptide Y (NPY), can prevent our immune system functioning properly, paving the way for two new major opportunities for therapeutic intervention.
Twenty states and the District of Columbia have agreed to expand their Medicaid programs, to cover everyone under 133 percent of the federal poverty line. That leaves 30 states that haven't, although Avalere categorizes four states as leaning in that direction (Tennessee, Kentucky, Florida and New York). Some of these states have especially large uninsured populations.
A shortage of oncologists and rising costs of chemotherapy and radiation therapies and imaging tests, are making delivering quality cancer care increasingly difficult, according to a new review by researchers at RTI International and Eli Lilly and Company.
› Verified 5 days ago
1622 Voorhies Ave Pharmacy Inc Type: Community/Retail Pharmacy Location: 1622 Voorhies Ave, Brooklyn, New York 11235 Phone: (347) 462-9778 | |
Clarkson Pharmacy Type: Pharmacy Location: 524 Clarkson Ave, Brooklyn, New York 11203 Phone: (718) 774-1656 | |
21 Ave Pharmacy And Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8511 21st Ave, Brooklyn, New York 11214 Phone: (718) 449-4949 | |
Val U Drugs Type: Medicare Supplier Location: 4623 Church Ave, Brooklyn, New York 11203 Phone: (718) 773-5547 | |
2818 Fulton Street Pharmacy Inc Type: Community/Retail Pharmacy Location: 2818 Fulton St, Brooklyn, New York 11207 Phone: (718) 235-6394 |